Caricamento...
Biologic therapies for Crohn’s disease: optimising the old and maximising the new
The era of biologic agents for the treatment of Crohn’s disease has brought about significant benefits for patients, and since the introduction of infliximab at the turn of the century, the entire field has moved on rapidly. Clinicians now have multiple agents at their disposal and a choice between...
Salvato in:
| Pubblicato in: | F1000Res |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
F1000 Research Limited
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6668046/ https://ncbi.nlm.nih.gov/pubmed/31448080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.18902.1 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|